Newsletter

Tech Stocks

Test text

ERoad (ASX:ERD): Set to benefit from a major tax reform forthcoming in New Zealand but just committed a cardinal sin

You may loathe the regulations on our roads and some companies that profit from them like Transurban, but ERoad (ASX:ERD) is a particularly unique company. And the reason we like it is because it could benefit from a new road regulation (specifically vehicle taxation) that is long overdue, happening in New Zealand and may in…

ByNick SundichOctober 17, 2025

Novonix (ASX: NVX) Falls 22% as BNY Mellon Boosts Holding to 10%, Signalling Long-Term Confidence

Novonix (ASX: NVX) is fast becoming one of the most closely watched names on the ASX and increasingly, in the U.S. market too. This week, shares fell 22% as investors appeared to consolidate gains after a strong run, but beneath the surface, a significant development quietly strengthened the company’s long-term outlook. The Bank of New…

ByCharlie YouldenOctober 16, 2025

This ASX semiconductor play is about to solve a major bottleneck

ASX semiconductor play Adisyn (ASX:AI1) is at a pivotal point in its development journey. By this time next year, the company is expected to have delivered a demonstration protype of its graphene disposition technology to build transistor interconnects, an area of semiconductor manufacturing that is starting to become a major bottleneck in advanced chip manufacturing. What…

ByNick SundichOctober 16, 2025

Archer Materials Jumps 25% After Major Quantum Technology Milestone

Archer Materials (ASX: AXE) jumped 25% today after the company announced a major breakthrough that could bring practical quantum computing one step closer to reality. Earlier this year, Archer proved it could detect quantum spin signals electrically, essentially showing it can observe how its qubits behave directly on a chip. This week, the company took…

ByCharlie YouldenOctober 15, 2025

Metallium Soars 10% as Rice University Collaboration Confirms U.S. Rare Earth Refining Potential

Following a strong peer-reviewed study published by Rice University, Metallium (ASX: MTM) has received a major credibility boost for its patented Flash Joule Heating (FJH) technology. The research confirmed the effectiveness of the process and its potential to advance U.S.-based rare earth refining capabilities, a key milestone given ongoing geopolitical tensions between China and the…

ByCharlie YouldenOctober 15, 2025

Solidion (NASDAQ: STI) Soars 293% on UPS AI Data Centre Battery Announcement

Solidion Technology (NASDAQ: STI) stunned the market this week, soaring 293 percent to USD $23 after unveiling a new proprietary semi-solid-state battery system designed for AI data centres. The breakthrough lies in its ability to act as an uninterruptible power supply, keeping servers online during outages while offering exceptional performance metrics. The system boasts an…

ByCharlie YouldenOctober 14, 2025

Rejecting a takeover offer: Here are 6 ASX stocks that did and how it ended for them

Rejecting a takeover offer is a bold step for an ASX company to take. It is turning down sweet quick cash for its shareholders and management. The argument most commonly made to reject them is that any offers are opportunistic and do not appropriately value the company - indeed, those very words are commonly used. The board…

ByNick SundichOctober 14, 2025

1414 Degrees (ASX: 14D) Secures Silicon Battery Technology from George Washington University

1414 Degrees Taps U.S. Innovation to Advance Next-Generation Battery Technology It is not every day that a small Australian energy company steps into the global battery race. Yet today, 1414 Degrees (ASX: 14D) announced an exclusive licence agreement with George Washington University to commercialise a breakthrough silicon nanoparticle technology designed for lithium-ion battery anodes. The opportunity…

ByCharlie YouldenOctober 9, 2025

Cyclopharm (ASX:CYC): FDA approved for 2 years now, but a lawsuit from 4DX is the latest headache and cause for investor scepticism

Cyclopharm (ASX:CYC) is a rare species - an ASX stock that is approved in the US market. However, its share price has gone in the opposite direction. Cyclopharm has not had as fast an uplift as other companies have had and still makes most of its sales from other jurisdictions. A lawsuit from 4D Medical…

ByNick SundichOctober 8, 2025

Activist investors: Here’s what you need to know about them and 4 famous Australian activists to watch out for

Hear the term 'Activist investors' and you might think of GetUp, the progressive activist group that forced Woolworths to hold an EGM in 2014 in an attempt to limit the maximum bets on poker machines to $1. Or perhaps even of ESG-focused fundies like Australian Ethical (ASX:AEF). The reality is a lot more complicated and…

ByNick SundichOctober 8, 2025

the Kick-ass Multipurpose WordPress Theme

Tech Stocks

ERoad (ASX:ERD): Set to benefit from a major tax reform forthcoming in New Zealand but just committed a cardinal sin

Novonix (ASX: NVX) Falls 22% as BNY Mellon Boosts Holding to 10%, Signalling Long-Term Confidence

This ASX semiconductor play is about to solve a major bottleneck

Archer Materials Jumps 25% After Major Quantum Technology Milestone

Metallium Soars 10% as Rice University Collaboration Confirms U.S. Rare Earth Refining Potential

Solidion (NASDAQ: STI) Soars 293% on UPS AI Data Centre Battery Announcement

Rejecting a takeover offer: Here are 6 ASX stocks that did and how it ended for them

1414 Degrees (ASX: 14D) Secures Silicon Battery Technology from George Washington University

Cyclopharm (ASX:CYC): FDA approved for 2 years now, but a lawsuit from 4DX is the latest headache and cause for investor scepticism

Activist investors: Here’s what you need to know about them and 4 famous Australian activists to watch out for

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Tech Stocks

Stocks in Spotlight

Add Your Heading Text Here